We are live on
!
Find out more
AbCellera Biologics
ABCL
ABCL
114 hedge funds and large institutions have $1.99B invested in AbCellera Biologics in 2021 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 50 increasing their positions, 8 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
525% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 8
140% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 20
43% more call options, than puts
Call options by funds: $32.1M | Put options by funds: $22.5M
33% more funds holding
Funds holding: 86 → 114 (+28)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
6.61% more ownership
Funds ownership: 26.81% → 33.42% (+6.6%)
18% less capital invested
Capital invested by funds: $2.42B → $1.99B (-$431M)
Holders
114
Holders Change
+28
Holders Change %
+32.56%
% of All Funds
1.98%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
48
Increased
50
Reduced
8
Closed
20
Calls
$32.1M
Puts
$22.5M
Net Calls
+$9.59M
Net Calls Change
+$8.66M
Top Buyers
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$648M |
| 2 |
O
OrbiMed
New York
|
-$54.5M |
| 3 |
AWG
Alpha Wave Global
New York
|
-$30M |
| 4 |
DFO
Duquesne Family Office
New York
|
-$22.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$17.8M |
